HUMALOG Trademark

Trademark Overview

On Tuesday, September 15, 1992, a trademark application was filed for HUMALOG with the United States Patent and Trademark Office. The USPTO has given the HUMALOG trademark a serial number of 74314093. The federal status of this trademark filing is REGISTERED AND RENEWED as of Friday, April 22, 2016. This trademark is owned by Eli Lilly and Company. The HUMALOG trademark is filed in the Pharmaceutical Products category with the following description:

insulin
humalog

General Information

Serial Number74314093
Word MarkHUMALOG
Filing DateTuesday, September 15, 1992
Status800 - REGISTERED AND RENEWED
Status DateFriday, April 22, 2016
Registration Number1963572
Registration DateTuesday, March 19, 1996
Mark Drawing1 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, February 23, 1993

Trademark Statements

Goods and Servicesinsulin
Pseudo MarkHUMA-LOG

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, October 26, 1992
Primary Code005
First Use Anywhere DateThursday, October 13, 1994
First Use In Commerce DateThursday, October 13, 1994

Trademark Owner History

Party NameEli Lilly and Company
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285
Party NameEli Lilly and Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285
Party NameEli Lilly and Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Trademark Events

Event DateEvent Description
Tuesday, December 15, 1992ASSIGNED TO EXAMINER
Friday, December 18, 1992APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, January 22, 1993NOTICE OF PUBLICATION
Tuesday, February 23, 1993PUBLISHED FOR OPPOSITION
Tuesday, September 14, 1993NOA MAILED - SOU REQUIRED FROM APPLICANT
Thursday, February 17, 1994SOU EXTENSION 1 FILED
Wednesday, April 13, 1994SOU EXTENSION 1 GRANTED
Tuesday, July 19, 1994USE AMENDMENT FILED
Tuesday, September 6, 1994SOU EXTENSION 2 FILED
Thursday, October 13, 1994SOU EXTENSION 2 GRANTED
Thursday, October 13, 1994STATEMENT OF USE PROCESSING COMPLETE
Friday, January 13, 1995ASSIGNED TO EXAMINER
Wednesday, December 13, 1995ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, March 19, 1996REGISTERED-PRINCIPAL REGISTER
Friday, March 1, 2002REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
Saturday, April 27, 2002REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Thursday, March 2, 2006TEAS SECTION 8 & 9 RECEIVED
Thursday, March 2, 2006REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED
Thursday, June 1, 2006ASSIGNED TO PARALEGAL
Tuesday, June 13, 2006REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Tuesday, June 13, 2006REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Monday, August 14, 2006CASE FILE IN TICRS
Tuesday, February 16, 2016TEAS SECTION 8 & 9 RECEIVED
Friday, April 22, 2016CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, April 22, 2016REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Friday, April 22, 2016REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
Friday, April 22, 2016NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Wednesday, March 19, 2025COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

Related Keywords

humalog insulin